Autoantibodies in nonautoimmune individuals during infections

Annals of the New York Academy of Sciences

Volumn 1108, Issue , 2007, Pages 584-593

  Berlin, Tatiana ^a,b   Zandman Goddard, Gisele ^b,c   Blank, Miri ^b,d   Matthias, Torsten ^e   Pfeiffer, Sascha ^e   Weis, Ingrid ^e   Toubi, Elias ^f,g   Singh, Sham ^h,i   Asherson, Ronald ^h,i   Fraser, Abigail ^j   Gilburd, Boris ^b,d   Sapir, Tal ^b,d   Levy, Yair ^a,b   Lukač, Janja ^k   Rozman, Blaž ^k   Kveder, Tanja ^k   Shoenfeld, Yehuda ^b,d  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c WOLFSON MEDICAL CENTER   (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

^e Research for Human Health   (Germany)

^f BNAI ZION MEDICAL CENTER   (Israel)

^g TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^h UNIVERSITY OF CAPE TOWN   (South Africa)

ⁱ Rosebank Clinic   (South Africa)

^j RABIN MEDICAL CENTER   (Israel)

^k UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

more..

Author keywords

Autoantibodies; Infections

Indexed keywords

AUTOANTIBODY; LAMININ; LIPOCORTIN 5; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY; PROTHROMBIN; THYROGLOBULIN; THYROID PEROXIDASE;

ANTIBODY SPECIFICITY; ANTIBODY TITER; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIAL INFECTION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS A; HEPATITIS B; HUMAN; HUMAN TISSUE; INFECTION; MAJOR CLINICAL STUDY; PARASITOSIS; Q FEVER; SACCHAROMYCES CEREVISIAE; SERUM; TOXOPLASMA; VIRUS INFECTION;

BACTERIA (MICROORGANISMS); SACCHAROMYCES CEREVISIAE; TOXOPLASMA;

EID: 34948828006     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1422.061     Document Type: Conference Paper

References (39)

1. ZANDMAN-GODDARD, G. & Y. SHOENFELD. 2005. Infections and SLE. Autoimmunity 38: 473-485.
2. PENDER, M.P. 2003. Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune disease. Trends Immunol. 24: 584-588.
3. PORTIS, T., M. IKEDA & R. LONGNECKER. 2004. Epstein-Barr virus LMP 2A: regulating cellular ubiquitination processes for maintenance of viral latency? Trends Immunol. 25: 422-426.
4. ADLER, B., G.W. BOTNKAMM, J. MAUTNER, et al. 2005. Epstein-Barr virus latent membrane protein 2A mimics B cell receptor-dependent virus reactivation. J. Gen. Virol. 86: 551-559.
5. CERVERA, R., R.A. ASHERSON, M.L. ACEVEDO, et al. 2004. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann. Rheum. Dis. 63: 1312-1317.
6. BLANK, M., I. KRAUSE, M. FRIDKIN, et al. 2002. Bacterial induction of autoantibodies to beta-2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J. Clin. Invest. 109: 797-804.
7. VRBIKOVA, J., I. JANATKOVA, V. ZAMRAZIL, et al. 1996. Epstein-Barr virus serology in patients with autoimmune thyroiditis. Exp. Clin. Endocrinol. 104: 89-92.
8. DUCLOS-VALLEE, J.C., C. JOHANET, J.C. TRINCHET, et al. 1994. High prevalence of serum antibodies to hepatitis C virus in patients with Hashimoto's thyroiditis. BMJ 309: 846-847.
9. BENZ, J. & A. HOFMANN. 1997. Annexins: from structure to function. Biol. Chem. 378: 177-183.
10. NAKAMURA, N., Y. SHIDARA, N. KAWAGUCHI, et al. 1994. Lupus anticoagulant autoantibody induces apoptosis in umbilical vein endothelial cells: involvement of annexin-V. Biochem. Biophys. Res. Commun. 205: 1488-1493.
11. SATOH, A., K. SUZUKI, E. TAKAYAMA, et al. 1999. Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. J. Rheumatol. 26: 1715-1720.
12. SUGIURA, K. & Y. MURO. 1999. Anti-annexin-V antibodies and digital ischemia in patients with scleroderma. J. Rheumatol. 26: 2168-2172.
13. SORICE, M., V. PITTINO, T. GRIGGI, et al. 2000. Specificity of anti-phospholipid antibodies in infectious mononucleosis: a role for anti-cofactor protein antibodies. Clin. Exp. Immunol. 120: 301-306.
14. GABRIELLI, A., M. MONTRONI, S. RUPOLI, et al. 1988. A retrospective study of antibodies against basement membrane antigens (type IV collagen and laminin) in patients with primary and secondary Raynaud's phenomenon. Arthritis Rheum. 31: 1432-1436.
15. HUFFSTUTTER, J.E., F.A. DELUSTRO & E.C. LEROY. 1985. Cellular immunity to collagen and laminin in scleroderma. Arthritis Rheum. 28: 775-780.
16. PEUTZ-KOOTSTRA, C.J., K. HANSEN, E. DE HEER, et al. 2000. Differential expression of laminin chains and anti-laminin autoantibodies in experimental lupus nephritis. J. Pathol. 192: 404-412.
17. AMITAL, H., M. HEILWEIL, R. ULMANSKY, et al. Treatment with a laminin-derived peptide suppresses lupus nephritis. 2005. J. Immunol. 175: 5516-5523.
18. STOJANOVIC, M., A. INIC-KANADA, Z. POPOVIC, et al. 2004. Changes in pools of autoantibodies and anti-bacterial antibodies in patients suffering from recurrent infections of the urinary tract and undergoing bacterial immunization treatment. Immunol. Lett. 94: 123-133.
19. ZANETTI, F.R., D. PLESTER, R. KLEIN, et al. 1989. Anti-laminin antibodies in inner ear diseases: a potential marker for infectious and post-infectious processes. Arch. Otorhinolaryngol. 246: 100-104.
20. GAZZINELLI, R., L.M. GALVAO, J.C. DIAS, et al. Anti-laminin and specific antibodies in acute Chagas disease. 1988. Trans. R. Soc. Trop. Med. Hyg. 82: 574-576.
21. GARCIA LERMA, J., I. MONEO, M. ORTIZ DE LANDAZURI, et al. 1995. Comparison of the anti-laminin antibody response in patients with systemic lupus erythematosus (SLE) and parasitic diseases (filariasis). Clin. Immunol. Immunopathol. 76: 19-31.
22. GALLI, M., D. LUCIANI, G. BERTOLINI, et al. 2003. Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 102: 2717-2723.
23. ATSUMI, T., M. IEKO, M.L. BERTOLACCINI, et al. 2000. Association of autoantibodies against the phosphatidylserine- prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum. 43: 1982-1993.
24. PALOMO, I., M. ALARCON, C. SEPULVEDA, et al. 2003. Prevalence of antiphospholipid and antiplatelet antibodies in human immunodeficiency virus (HIV)-infected Chilean patients. J. Clin. Lab. Anal. 17: 209-215.
25. LOIZOU, S., S. SINGH, E. WYPKEMA, et al. 2003. Anticardiolipin, anti- β2-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease. Ann. Rheum. Dis. 62: 1106-1011.
26. GUERIN, J., O. SMITH, B. WHITE, et al. 1998. Antibodies to prothrombin in antiphospholipid syndrome and inflammatory disorders. Br. J. Haematol. 102: 896-902.
27. ARVIEUX, J.Y., RENAUDINEAU, I. MANE, et al. 2002. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome. Thromb. Haemost. 87: 599-605.
28. DE LARRANAGA, G.F., R.R. FORASTIERO, M.E. MARTINUZZO, et al. 2000. High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity. Lupus 9: 594-600.
29. LEROY, V., J. ARVIEUX, M.C. JACOB, et al. 1998. Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C. Br. J. Haematol. 101: 468-474.
30. HOFFMAN, I.E., P. DEMETTER, M. PEETERS, et al. 2003. Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy. Ann. Rheum. Dis. 62: 455-459.
31. MURATORI, P., L. MURATORI, M. GUIDI, et al. 2003. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin. Exp. Immunol. 132: 473-476.
32. KRAUSE, I., Y. MONSELISE, G. MILO, et al. 2002. Anti-Saccharomyces cerevisiae antibodies - a novel serologic marker for Behcet's disease. Clin. Exp. Rheumatol. 20: 21-24.
33. ZANDMAN-GODDARD, G., M. BLANK & Y. SHOENFELD. 2002. Antiphospholipid antibodies and infections-drugs. In The Antiphospholipid Syndrome II: Autoimmune Thrombosis. R. Asherson, R. Cervera, J.C. Pietle & Y. Shoenfeld, Eds.: 343-358. Elsevier. Amsterdam.
34. ORDI-ROS, J., A. SELVA-O'CALLAGHAN, F. MONEGAL-FERRAN, et al. 1994. Prevalence, significance, and specificity of antibodies to phospholipids in Q fever. Clin. Infect. Dis. 18: 213-218.
35. NIELEN, M.M., D. VAN SCHAARDENBURG, H.W. REESINK, et al. 2004. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 50: 380-386.
36. ARBUCKLE, M.R., M.T. MCCLAIN, M.V. RUBERTONE, et al. 2003. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349: 1526-1533.
37. LAGASSE, J.M., M.S. BRANTLEY, N.J. LEECH, et al. 2002. Washington State Diabetes Prediction Study. Successful prospective prediction of type 1 diabetes in school children through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study. Diabetes Care 25: 505-511.
38. ISRAELI, E., I. GROTTO, B. GILBURD, et al. 2005. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 54: 1232-1236.
39. SCOFIELD, R.H. 2004. Autoantibodies as predictors of disease. Lancet 363: 1544-1546.